Why the study?
The mechanisms linking metabolic dysfunction to HFrEF remain incompletely understood, requiring robust animal models that recapitulate human HFrEF for mechanistic investigation and therapeutic development.
Does a Western diet supplemented with trimethylamine N-oxide (TMAO) induce heart failure with reduced ejection fraction (HFrEF) in male C57BL/6N mice?
Does a Western diet supplemented with trimethylamine N-oxide (TMAO) induce heart failure with reduced ejection fraction (HFrEF) in male C57BL/6N mice?
Combining a Western diet with TMAO in male mice establishes a novel non-surgical, non-genetic preclinical model that recapitulates progressive cardiometabolic HFrEF, cardiac remodelling, and pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
Does not alter clinical HFrEF management; extends non-surgical cardiometabolic models for preclinical research.
Background/Objectives: Metabolic dysfunction is increasingly recognised as a key contributor to heart failure with reduced ejection fraction (HFrEF), yet the underlying mechanisms remain incompletely understood. Therefore, robust animal models that recapitulate human HFrEF are needed for mechanistic investigation and therapeutic development. We aimed to establish and characterise a novel non-surgical, non-genetic model using Western diet (WD) supplemented with trimethylamine N-oxide (TMAO). Methods: Six-week-old male C57BL/6N mice received Chow, Chow+TMAO, WD, or WD+TMAO for 15 weeks. Metabolic and cardiac functional assessment, and lung ultrasound were performed longitudinally, followed by invasive haemodynamic assessment, histological and transmission electron microscopy analyses, and myocardial gene expression analysis at week 15. Results: Mice subjected to WD+TMAO developed metabolic dysfunction from week 5, including obesity, glucose intolerance, and sustained systolic hypertension followed by diastolic hypertension. Left ventricular ejection fraction (LVEF) declined progressively, with mean values of 60.2%, 58.0%, and 44.7% at weeks 5, 10, and 15, respectively. At week 15, LVEF was significantly lower than that in the Chow, TMAO, and WD groups (all p < 0.0001). This reduction was accompanied by reduced cardiac output and LV dP/dtmax, pulmonary hypertension, increased cardiac hypertrophic and fibrotic remodelling, marked intracellular lipid accumulation, downregulation of Ppargc1a and Ppara, and upregulation of Nppa. Importantly, overt HFrEF and its associated abnormalities were absent in mice subjected to WD or TMAO alone. Conclusions: WD+TMAO induces progressive HFrEF, cardiac remodelling and pulmonary hypertension in male mice. This non-surgical, non-genetic HF model provides a useful platform for mechanistic investigation and therapeutic evaluation of cardiometabolic HFrEF.
No takes yet. Share an insight, caveat, or question.
Baudry et al. (2026) studied Heart failure with reduced ejection fraction (HFrEF) preclinical mouse model. Western diet supplemented with trimethylamine N-oxide (WD+TMAO) vs. Chow, Chow+TMAO, or Western diet (WD) alone was evaluated on Left ventricular ejection fraction (LVEF) at week 15 (p=<0.0001).
Synapse has enriched 10 related papers. Consider them for comparative context: